StockIQpro
NASDAQ:SGHT

Sight Sciences, Inc.

Sight Sciences, Inc.'s revenue fell 3.1% in fiscal 2025 to $77.4M while operating margin rose to −48.0%, its highest in 6 years. Free cash flow was −$29.9M, −38.7% of revenue, and the diluted share count rose 4.0%.Summary generated from Sight Sciences, Inc.'s SEC filings. Latest annual report filed Mar 4, 2026.

Revenue (FY25)$77.4M
Revenue growth−3.1%
Revenue, 5-yr CAGR+22.9%
Gross margin86.2%
Operating margin−48.0%
Net margin−49.7%
ROIC−272.3%
Return on equity−50.7%
Debt / equity0.66
Free cash flow−$29.9M
FCF margin−38.7%
Share count change+4.0%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue4971818077
Operating income−51−84−57−51−37
Net income−63−86−56−52−38
Free cash flow−53−77−48−23−30

Recent filings

From SEC EDGAR

Peers

Surgical & medical instruments & apparatus